Codexis (CDXS) Work In Process (2011 - 2026)

Codexis' (CDXS) quarterly Work In Process came in at $441000.0 in Q1 2026, down 75.34% year-on-year from $1.8 million in Q1 2025, and down 10.37% quarter-over-quarter from $492000.0 in Q4 2025.

Codexis (CDXS) Work In Process (2011 - 2026) Analysis & Trends

Codexis' Work In Process history runs 16 years deep, the most recent figure standing at $441000.0 for Q1 2026.

  • On a quarterly basis, Work In Process fell 75.34% year-over-year to $441000.0 in Q1 2026; TTM through Mar 2026 was $441000.0, a 75.34% decrease from a year earlier, with the FY2025 full-year figure at $492000.0, down 88.75% from the prior year.
  • Work In Process slipped to $441000.0 in Q1 2026 per CDXS's latest filing, from $492000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $11.3 million in Q2 2022 and bottomed at $441000.0 in Q1 2026.
  • The 5-year median for Work In Process is $2.2 million (2023), against an average of $3.3 million.
  • Across the five-year window, Work In Process soared 436.81% in 2024 and plunged 88.75% in 2025, its largest moves.
  • Year by year, Work In Process stood at $2.1 million in 2022, then plunged by 61.48% to $815000.0 in 2023, then surged by 436.81% to $4.4 million in 2024, then plunged by 88.75% to $492000.0 in 2025, then dropped by 10.37% to $441000.0 in 2026.
  • Per Business Quant, the three latest CDXS Work In Process figures stand at $441000.0 (Q1 2026), $492000.0 (Q4 2025), and $2.1 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Codexis 180.63 Mn 115.49 Mn 13.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 441,000.00
Dec 31, 2025 492,000.00
Sep 30, 2025 2.13 Mn
Jun 30, 2025 1.28 Mn
Mar 31, 2025 1.79 Mn
Dec 31, 2024 4.38 Mn
Sep 30, 2024 3.42 Mn
Jun 30, 2024 3.21 Mn
Mar 31, 2024 2.57 Mn
Dec 31, 2023 815,000.00
Sep 30, 2023 1.94 Mn
Jun 30, 2023 2.25 Mn
Mar 31, 2023 2.45 Mn
Dec 31, 2022 2.12 Mn
Sep 30, 2022 5.87 Mn
Jun 30, 2022 11.29 Mn
Mar 31, 2022 9.75 Mn
Dec 31, 2021 4.56 Mn
Sep 30, 2021 12.70 Mn
Jun 30, 2021 4.53 Mn